Cancer Screening with Global Genetic Labs
Welcome to Global Genetic Labs, where your health and peace of mind are our top priorities. We offer a comprehensive range of genetic cancer screening panels designed to empower you with knowledge about your hereditary cancer risks. Our cutting-edge tests provide you with insights that can lead to life-saving early detection and prevention. By testing from the comfort of your home with our simple saliva swab kits, you’ll be taking a proactive step toward safeguarding your health and the well-being of your loved ones. Our state-of-the-art Genome Nanopore Sequencing (GNS) technology ensures high accuracy, with results delivered to your email in just 15 days.
Why Choose Genetic Cancer Screening?
Hereditary cancer accounts for 5-10% of all cancer cases, with specific genetic mutations significantly increasing your risk. Understanding your genetic predisposition allows for early interventions, regular screenings, and preventative measures that could make all the difference. Genetic testing is especially crucial if you have a family history of cancer, are of Ashkenazi Jewish descent, or have other known risk factors.
Discover our comprehensive range of cancer screening panels below.
Prostate cancer is the most common cancer among men in the UK. Our test identifies genetic mutations that increase your risk, such as BRCA2 and HOXB13.
Statistic: Men with BRCA2 mutations are 5 times more likely to develop prostate cancer.
Who It’s For: Men over 18, particularly those with a family history of prostate cancer.
Mutations Analysed: BRCA2, HOXB13, CHEK2.
Our Colorectal Cancer Panel tests for genetic mutations associated with colorectal cancer, such as those found in Lynch Syndrome.
Statistic: Colorectal cancer is the fourth most common cancer in the UK, with 42,000 new cases annually. Lynch Syndrome accounts for 3-5% of these.
Who It’s For: Individuals over 18 with a family history of colorectal or related cancers.
Mutations Analysed: MLH1, MSH2, MSH6, PMS2.
This panel screens for genetic risks associated with melanoma, a serious form of skin cancer.
Statistic: Around 16,000 new melanoma cases are diagnosed each year in the UK. Early detection significantly improves survival rates.
Who It’s For: Anyone over 18, especially those with a family history of skin cancer.
Mutations Analysed: CDKN2A, BAP1, MC1R.
Specifically designed to detect mutations in genes like BRCA1 and BRCA2, which are linked to breast cancer.
Statistic: In the UK, 1 in 8 women will develop breast cancer. BRCA1 and BRCA2 mutations increase this risk to 60-80% for BRCA1 carriers.
Who It’s For: Women and men over 18 with a family history of breast or related cancers.
Mutations Analysed: BRCA1, BRCA2, PALB2.
This test screens for mutations that increase the risk of both breast and gynaecological cancers, such as ovarian and uterine cancers.
Statistic: Women with BRCA1 mutations have a 39-46% lifetime risk of developing ovarian cancer.
Who It’s For: Women over 18, especially those with a family history of both breast and gynaecological cancers.
Mutations Analysed: BRCA1, BRCA2, RAD51C, RAD51D.
Our Pancreatic Cancer Panel identifies genetic mutations that elevate the risk of developing pancreatic cancer.
Statistic: Pancreatic cancer has a 5-year survival rate of just 7%, making early detection crucial.
Who It’s For: Individuals over 18, particularly those with a family history of pancreatic or related cancers.
Mutations Analysed: BRCA2, PALB2, ATM.
Frequently Asked Questions
Whether you’re looking to understand your cancer risk or gain insights into your family’s genetic health history, our tests provide a clear path forward. With easy, at-home saliva testing and reports delivered within 15 days, Global Genetic Labs makes genetic screening accessible and understandable for everyone.
